Bio-Solutions Corp.
OTC Bulletin Board : BISU

Bio-Solutions Corp.

November 10, 2009 08:30 ET

Bio-Solutions Corp. is Proud to Announce the Negotiation of Supply Agreement With the Government of 3 African Countries for GreenEx™ Its Main Product Targeting Malaria Vectors

MONTREAL, CANADA--(Marketwire - Nov. 10, 2009) - Bio-Solutions Corp. (OTCBB:BISU), is proud to announce the negotiation of a supply agreement for its main product GreenEx™ with three African Countries. This agreement will include the turn key operation of the spreading of GreenEx™ on highly infested sites within these countries.

'During our commercialization efforts of GreenEx™, we have realized that our integrated participative approach in highly infested countries gives Bio-Solutions Corp a significant competitive edge.' states Dr Chaumillon.

Management at Bio-Solutions Corp. has begun development activities less than 6 month ago in 3 countries. It allowed the company to validate its approach and to evaluate that it fulfils real needs. In a specific country, GreenEx™ has been regulatory approved to be used in a pilot study to demonstrate efficiency in a specific area highly infested and to confirm previous results obtained in different geographic area and different environmental conditions.

'It is important to mention that the environmental conditions and prevalent factors are area specific and require validation of spreading techniques in order to be adequately deployed. In that respect, due to the country specific project sizes, we need to develop partnership with health authority's upper management as well as respective government highest level of decision. Our intention is to develop long term multiple partnership to allow Bio-Solutions Corp. to reach profitability during the first year of operation and thus assure recurrent and significant revenues to the company while helping the fight against Malaria vectors, within these Malaria infested countries' indicated Dr Chaumillon.

For more information on Bio-Solutions Corp. and its products, please visit the company's website at

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbour provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions' actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of studies, the ability of the Company to take advantage of business opportunities in the biotechnology industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.

Contact Information